Study of infliximab treatment in smokers with COPD: what next?

Am J Respir Crit Care Med. 2005 Dec 15;172(12):1607-8; author reply 1608. doi: 10.1164/ajrccm.172.12.1607.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Humans
  • Immunologic Factors / pharmacology
  • Immunologic Factors / therapeutic use*
  • Infliximab
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Pulmonary Disease, Chronic Obstructive / immunology
  • Smoking* / immunology
  • Treatment Failure

Substances

  • Antibodies, Monoclonal
  • Immunologic Factors
  • Infliximab